While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...

Losing weight at today's fast pace can seem like running uphill. Countless supplements have invaded the market, and it ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Taking a supplement which is already popular for its heart, brain and immune system benefits may also help you live longer ...

Eli Lilly & Co. (LLY) thinks its next experimental weight-loss pill could get approved as soon as early 2026. CEO Dave Ricks told Bloomberg News on Monday that data on the drug, orforglipron ...

Over one in 20 men and one in 33 women have tried the fad diet according to new data from Asda Online Doctor 😟 ...

Danish weight-loss drug maker Novo Nordisk (NVO) is jumping 5% after the company reported higher-than-expected net income for ...

the company believe their product can provide a 10-20 per cent weight loss with regular use. “A couple of years ago there was an article published in Nature about an exercise pill that was based ...